SynBiotic is an investment vehicle that pursues an EU-focused buy-and-build approach. The core business of the platform company is the R&D of new cannabinoid and terpene-based solutions for the health issues of pain, sleep and anxiety.
Consumer |
Outlook
Consumer |
Outlook
Consumer |
Update
Consumer |
Update
Daniel Kruse
CEO